Table 5.

Risk of mortality in patients in the exposeda and unexposedb cohorts

Time period, monthsExposed cohortUnexposed matched cohortExposed versus unexposed
Events, n (%)Time at risk, person-yearsIncidence per 10 000 person-yearsEvents, n (%)Time at risk, person-yearsIncidence per 10 000 person-yearsAdjustedc HRe (95% CI)
All-cause0–63119 (4.1)35 962.2867.3423 (0.6)36 801.9114.96.0 (5.4 to 6.7)
>611 251 (14.9)462 060.6243.57726 (10.2)489 616.9157.81.2 (1.1 to 1.3)
COPD-related0–678 (0.1)35 962.221.75 (0.0)36 801.91.411.5 (4.5 to 28.9)
>61030 (1.4)462 060.622.3198 (0.3)489 616.94.01.8 (1.5 to 2.1)
IHD-related0–6452 (0.6)35 962.2125.770 (0.1)36 801.919.04.7 (3.6 to 6.2)
>62999 (4.0)462 060.664.91625 (2.1)489 616.933.21.2 (1.1 to 1.3)
  • a Patients with recorded breathlessness.

  • b Patients without recorded breathlessness.

  • c Adjusted for: index year; age; sex; region; smoker, ever; alcohol drinker, ever; BMI; deprivation level; comorbidity; cough and sputum; inflammatory conditions; depression and anxiety; diabetes; non-specific chest pain; musculoskeletal pain; later diagnosis. Later diagnosis as a time-varying covariate: for all-cause mortality, later diagnosis is the earliest diagnosis of asthma, COPD, or IHD.

  • e Sub-distribution HR was used in completing risk models for disease-specific mortality (other death was treated as competing events) and in Cox models for all-cause mortality. BMI = body mass index. COPD = chronic obstructive pulmonary disease. HR = hazard ratio. IHD = ischaemic heart disease.